These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 19280995)

  • 21. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two- and three-locus haplotypes of the paraoxonase (PON1) gene are associated with coronary artery disease in Asian Indians.
    Ahmad I; Narang R; Venkatraman A; Das N
    Gene; 2012 Sep; 506(1):242-7. PubMed ID: 22750797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.
    Gupta N; Binu KB; Singh S; Maturu NV; Sharma YP; Bhansali A; Gill KD
    Gene; 2012 Apr; 498(1):13-9. PubMed ID: 22333293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction].
    Guxens M; Tomás M; Elosua R; Aldasoro E; Segura A; Fiol M; Sala J; Vila J; Fullana M; Sentí M; Vega G; de la Rica M; Marrugat J;
    Rev Esp Cardiol; 2008 Mar; 61(3):269-75. PubMed ID: 18361900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease.
    Martinelli N; Girelli D; Olivieri O; Cavallari U; Biscuola M; Trabetti E; Friso S; Pizzolo F; Tenuti I; Bozzini C; Villa G; Ceradini B; Sandri M; Cheng S; Grow MA; Pignatti PF; Corrocher R
    Clin Exp Med; 2005 May; 5(1):20-30. PubMed ID: 15928879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
    Najafi M; Gohari LH; Firoozrai M
    Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
    Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
    Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The different genotypes of MTHFR 1298A>C and PON1 -108C>T polymorphisms confer the increased risk of the abdominal aortic aneurysm in the smoking and nonsmoking persons].
    Strauss E; Waliszewski K; Pawlak AL
    Przegl Lek; 2005; 62(10):1023-30. PubMed ID: 16521945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population.
    Berdeli A; Sekuri C; Sirri Cam F; Ercan E; Sagcan A; Tengiz I; Eser E; Akin M
    Clin Chim Acta; 2005 Jan; 351(1-2):87-94. PubMed ID: 15563875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
    Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
    Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
    Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
    Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.
    Gluba A; Pietrucha T; Banach M; Piotrowski G; Rysz J
    Angiology; 2010 Feb; 61(2):157-65. PubMed ID: 19939821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase gene polymorphisms and sporadic ALS.
    Slowik A; Tomik B; Wolkow PP; Partyka D; Turaj W; Malecki MT; Pera J; Dziedzic T; Szczudlik A; Figlewicz DA
    Neurology; 2006 Sep; 67(5):766-70. PubMed ID: 16822965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
    Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.